{"id":3940,"date":"2016-10-25T08:58:48","date_gmt":"2016-10-25T08:58:48","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/poster\/drug-discovery-approaches-for-epigenetic-targets\/"},"modified":"2025-12-12T11:36:15","modified_gmt":"2025-12-12T11:36:15","slug":"drug-discovery-approaches-for-epigenetic-targets","status":"publish","type":"poster","link":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/","title":{"rendered":"Drug Discovery Approaches for Epigenetic Targets"},"content":{"rendered":"<p><span style=\"font-size: 14pt;\">Unveiling the Power of Epigenetics in Disease Etiology: Novel Therapeutic Opportunities Explored<\/span><\/p>\n<p>The growing recognition of epigenetics&rsquo; pivotal role in cancer and various diseases has shed light on exciting possibilities for innovative therapies. Sygnature Discovery, in its pursuit of effective epigenetic drug discovery programs, has tackled challenges related to compound promiscuity in early stages by introducing a diverse array of methodologies. These encompass biochemical, biophysical, cellular target engagement, and biomarker approaches. This poster delves into two distinct epigenetic projects, showcasing breakthroughs in Deubiquitinase (DUB) and Bromodomain targets, each poised to shape the future of medical interventions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sygnature Discovery: Advancing therapies with DUB and Bromodomain targets in epigenetics. Cutting-edge insights in this poster<\/p>\n","protected":false},"featured_media":2577,"template":"","category":[1],"class_list":["post-3940","poster","type-poster","status-publish","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Epigenetics in Drug Discovery: DUB and Bromodomain Targets<\/title>\n<meta name=\"description\" content=\"Sygnature Discovery: Advancing therapies with DUB and Bromodomain targets in epigenetics. Cutting-edge insights in this poster.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Epigenetics in Drug Discovery: DUB and Bromodomain Targets\" \/>\n<meta property=\"og:description\" content=\"Sygnature Discovery: Advancing therapies with DUB and Bromodomain targets in epigenetics. Cutting-edge insights in this poster.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-12T11:36:15+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Q-Epigenetics-Bio-Methods-Poster-712x1024.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"712\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/drug-discovery-approaches-for-epigenetic-targets\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/drug-discovery-approaches-for-epigenetic-targets\\\/\",\"name\":\"Epigenetics in Drug Discovery: DUB and Bromodomain Targets\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/drug-discovery-approaches-for-epigenetic-targets\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/drug-discovery-approaches-for-epigenetic-targets\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Q-Epigenetics-Bio-Methods-Poster-scaled.jpg\",\"datePublished\":\"2016-10-25T08:58:48+00:00\",\"dateModified\":\"2025-12-12T11:36:15+00:00\",\"description\":\"Sygnature Discovery: Advancing therapies with DUB and Bromodomain targets in epigenetics. Cutting-edge insights in this poster.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/drug-discovery-approaches-for-epigenetic-targets\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/drug-discovery-approaches-for-epigenetic-targets\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/drug-discovery-approaches-for-epigenetic-targets\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Q-Epigenetics-Bio-Methods-Poster-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Q-Epigenetics-Bio-Methods-Poster-scaled.jpg\",\"width\":1781,\"height\":2560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/drug-discovery-approaches-for-epigenetic-targets\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Drug Discovery Approaches for Epigenetic Targets\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Epigenetics in Drug Discovery: DUB and Bromodomain Targets","description":"Sygnature Discovery: Advancing therapies with DUB and Bromodomain targets in epigenetics. Cutting-edge insights in this poster.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/","og_locale":"fr_CA","og_type":"article","og_title":"Epigenetics in Drug Discovery: DUB and Bromodomain Targets","og_description":"Sygnature Discovery: Advancing therapies with DUB and Bromodomain targets in epigenetics. Cutting-edge insights in this poster.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/","og_site_name":"Sygnature","article_modified_time":"2025-12-12T11:36:15+00:00","og_image":[{"width":712,"height":1024,"url":"http:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Q-Epigenetics-Bio-Methods-Poster-712x1024.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/","name":"Epigenetics in Drug Discovery: DUB and Bromodomain Targets","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Q-Epigenetics-Bio-Methods-Poster-scaled.jpg","datePublished":"2016-10-25T08:58:48+00:00","dateModified":"2025-12-12T11:36:15+00:00","description":"Sygnature Discovery: Advancing therapies with DUB and Bromodomain targets in epigenetics. Cutting-edge insights in this poster.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Q-Epigenetics-Bio-Methods-Poster-scaled.jpg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Q-Epigenetics-Bio-Methods-Poster-scaled.jpg","width":1781,"height":2560},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/drug-discovery-approaches-for-epigenetic-targets\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"Drug Discovery Approaches for Epigenetic Targets"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/3940","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/poster"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/3940\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/2577"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=3940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=3940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}